Late Breaking Trials: Scientific Sessions – Chicago 2018

Cardiovascular risk assessment is a process, not just a calculation! This year, I was very pleased to attend the 2018 guidelines for cholesterol management at the American Heart Association (AHA) Scientific Sessions – Chicago 2018. I highly recommend that you check the guidelines as there are many changes that may impact your daily practice. Here, … Read more

Beyond Embargoes: A Vision for Future Scientific Sessions

At my first two AHA Scientific Sessions, I sat in the Main Event Hall, shoulder-to-shoulder with my co-fellows, eagerly awaiting the results of the Late Breaking Clinical Trials and guideline updates. I remember whispers cascading across the room after the presentation of NEAT-HFpEF in 2015 and the hundreds of cellphones in the air snapping pictures … Read more